Terms: = Endocrine gland cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
127 results:
1. Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma.
Li F; Si W; Xia L; Yin D; Wei T; Tao M; Cui X; Yang J; Hong T; Wei R
Mol Cancer; 2024 May; 23(1):90. PubMed ID: 38711083
[TBL] [Abstract] [Full Text] [Related]
2. Lactate enhances NMNAT1 lactylation to sustain nuclear NAD
Huang H; Wang S; Xia H; Zhao X; Chen K; Jin G; Zhou S; Lu Z; Chen T; Yu H; Zheng X; Huang H; Lan L
Cancer Lett; 2024 Apr; 588():216806. PubMed ID: 38467179
[TBL] [Abstract] [Full Text] [Related]
3. Nanoparticle Targeting in Chemo-Resistant Ovarian cancer Reveals Dual Axis of Therapeutic Vulnerability Involving Cholesterol Uptake and Cell Redox Balance.
Wang Y; Calvert AE; Cardenas H; Rink JS; Nahotko D; Qiang W; Ndukwe CE; Chen F; Keathley R; Zhang Y; Cheng JX; Thaxton CS; Matei D
Adv Sci (Weinh); 2024 Apr; 11(13):e2305212. PubMed ID: 38263873
[TBL] [Abstract] [Full Text] [Related]
4. ep300 promotes ferroptosis via HSPA5 acetylation in pancreatic cancer.
Wang Y; Liu Y; Wang C; Kang R; Tang D; Liu J
Sci Rep; 2023 Sep; 13(1):15004. PubMed ID: 37696842
[TBL] [Abstract] [Full Text] [Related]
5. Inhibition of p300 increases cytotoxicity of cisplatin in pancreatic cancer cells.
Bugbee T; Gathoni M; Payne C; Blubaugh M; Matlock K; Wixson T; Lu A; Stancic S; Chung PA; Palinski R; Wallace N
Gene; 2023 Dec; 888():147762. PubMed ID: 37666373
[TBL] [Abstract] [Full Text] [Related]
6. Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression.
Zheng Y; Zhu L; Qin ZY; Guo Y; Wang S; Xue M; Shen KY; Hu BY; Wang XF; Wang CQ; Qin LX; Dong QZ
Cell Rep; 2023 Jul; 42(7):112666. PubMed ID: 37347667
[TBL] [Abstract] [Full Text] [Related]
7. Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genes.
Møller NB; Boonen DS; Feldner ES; Hao Q; Larsen M; Lænkholm AV; Borg Å; Kvist A; Törngren T; Jensen UB; Boonen SE; Thomassen M; Terkelsen T
Sci Rep; 2023 May; 13(1):8536. PubMed ID: 37237042
[TBL] [Abstract] [Full Text] [Related]
8. EGR1 induces EMT in pancreatic cancer via a p300/SNAI2 pathway.
Wang Y; Qin C; Zhao B; Li Z; Li T; Yang X; Zhao Y; Wang W
J Transl Med; 2023 Mar; 21(1):201. PubMed ID: 36932397
[TBL] [Abstract] [Full Text] [Related]
9. The expression of HDAC9 and p300 in papillary thyroid carcinoma cell line.
Ozisik H; Ozdil B; Suner A; Sipahi M; Erdogan M; Cetinkalp S; Ozgen G; Saygili F; Oktay G; Aktug H
Pathol Res Pract; 2023 Mar; 243():154385. PubMed ID: 36857949
[TBL] [Abstract] [Full Text] [Related]
10. GLI1 interaction with p300 modulates SDF1 expression in cancer-associated fibroblasts to promote pancreatic cancer cells migration.
Vera RE; Lamberti MJ; Almada LL; Tolosa EJ; Vrabel AM; Sigafoos AN; Toruner MD; Flores LF; Rivarola VA; Rumie Vittar NB; Fernández-Zapico ME
Biochem J; 2023 Feb; 480(3):225-241. PubMed ID: 36734208
[TBL] [Abstract] [Full Text] [Related]
11. Skp2-mediated Zeb1 expression facilitates cancer migration by a ubiquitination-independent pathway.
Wang HC; Luo CW; Chen TY; Chen YZ; Fang SY; Lai CY; Hung WC; Wu CC; Chen LT; Liu YC; Pan MR
Life Sci; 2022 Dec; 311(Pt A):121135. PubMed ID: 36349605
[TBL] [Abstract] [Full Text] [Related]
12. Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance.
Cheng A; Rao Q; Liu Y; Huang C; Li J; Huo C; Lin Z; Lu H
Gynecol Oncol; 2022 Dec; 167(3):502-512. PubMed ID: 36270832
[TBL] [Abstract] [Full Text] [Related]
13. Network Pharmacology, Molecular Docking, and Experimental Validation to Unveil the Molecular Targets and Mechanisms of Compound Fuling Granule to Treat Ovarian cancer.
Li Z; Liu Q; Zhu Y; Wu L; Liu W; Li J; Zhang Z; Tao F
Oxid Med Cell Longev; 2022; 2022():2896049. PubMed ID: 36062197
[TBL] [Abstract] [Full Text] [Related]
14. The Identification by Exome Sequencing of Candidate Genes in
BenAyed-Guerfali D; Kifagi C; BenKridis-Rejeb W; Ammous-Boukhris N; Ayedi W; Khanfir A; Daoud J; Mokdad-Gargouri R
Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 35893033
[TBL] [Abstract] [Full Text] [Related]
15. Patterns and Impact of Fragmented Care in Stage II and III Gastric cancer.
Rhodin KE; Raman V; Eckhoff A; Liu A; Creasy J; Nussbaum DP; Blazer DG
Ann Surg Oncol; 2022 Sep; 29(9):5422-5431. PubMed ID: 35723791
[TBL] [Abstract] [Full Text] [Related]
16. Exosome-derived FGD5-AS1 promotes tumor-associated macrophage M2 polarization-mediated pancreatic cancer cell proliferation and metastasis.
He Z; Wang J; Zhu C; Xu J; Chen P; Jiang X; Chen Y; Jiang J; Sun C
Cancer Lett; 2022 Nov; 548():215751. PubMed ID: 35718269
[TBL] [Abstract] [Full Text] [Related]
17. A p300/GATA6 axis determines differentiation and Wnt dependency in pancreatic cancer models.
Zhong Z; Harmston N; Wood KC; Madan B; Virshup DM
J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35536676
[TBL] [Abstract] [Full Text] [Related]
18. LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma.
Liu Y; Shi M; He X; Cao Y; Liu P; Li F; Zou S; Wen C; Zhan Q; Xu Z; Wang J; Sun B; Shen B
J Hematol Oncol; 2022 May; 15(1):52. PubMed ID: 35526050
[TBL] [Abstract] [Full Text] [Related]
19. The p300 Inhibitor A-485 Exerts Antitumor Activity in Growth Hormone Pituitary Adenoma.
Ji C; Xu W; Ding H; Chen Z; Shi C; Han J; Yu L; Qiao N; Zhang Y; Cao X; Zhou X; Cheng H; Feng H; Luo C; Li Z; Zhou B; Ye Z; Zhao Y
J Clin Endocrinol Metab; 2022 May; 107(6):e2291-e2300. PubMed ID: 35247260
[TBL] [Abstract] [Full Text] [Related]
20. The CTCF/LncRNA-PACERR complex recruits E1A binding protein p300 to induce pro-tumour macrophages in pancreatic ductal adenocarcinoma via directly regulating PTGS2 expression.
Liu Y; Wang X; Zhu Y; Cao Y; Wang L; Li F; Zhang Y; Li Y; Zhang Z; Luo J; Deng X; Peng C; Wei G; Chen H; Shen B
Clin Transl Med; 2022 Feb; 12(2):e654. PubMed ID: 35184402
[TBL] [Abstract] [Full Text] [Related]
[Next]
